Annual EBITDA
-$76.35 M
-$228.82 M-150.08%
December 31, 2023
Summary
- As of February 10, 2025, MOR annual EBITDA is -$76.35 million, with the most recent change of -$228.82 million (-150.08%) on December 31, 2023.
- During the last 3 years, MOR annual EBITDA has fallen by -$134.37 million (-231.61%).
Performance
MOR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
$59.38 M
+$115.99 M+204.87%
December 31, 2023
Summary
- As of February 10, 2025, MOR quarterly EBITDA is $59.38 million, with the most recent change of +$115.99 million (+204.87%) on December 31, 2023.
- Over the past year, MOR quarterly EBITDA has dropped by -$148.34 million (-71.41%).
Performance
MOR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$56.19 M
-$148.34 M-160.98%
December 31, 2023
Summary
- As of February 10, 2025, MOR TTM EBITDA is -$56.19 million, with the most recent change of -$148.34 million (-160.98%) on December 31, 2023.
- Over the past year, MOR TTM EBITDA has dropped by -$189.84 million (-142.04%).
Performance
MOR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MOR EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -150.1% | -71.4% | -142.0% |
3 y3 years | -231.6% | +143.0% | -227.6% |
5 y5 years | -15.5% | +143.0% | -227.6% |
MOR EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -150.1% | +698.2% | -71.4% | -946.1% | -129.0% | +1221.5% |
5 y | 5-year | -150.1% | +698.2% | -76.1% | -946.1% | -129.0% | +1221.5% |
alltime | all time | -150.1% | +698.2% | -76.1% | -946.1% | -129.0% | +1221.5% |
MorphoSys AG EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$76.35 M(-150.1%) | $59.38 M(-204.9%) | -$56.19 M(-161.0%) |
Sep 2023 | - | -$56.62 M(+27.1%) | $92.15 M(-52.4%) |
Jun 2023 | - | -$44.55 M(+209.4%) | $193.59 M(+5.5%) |
Mar 2023 | - | -$14.40 M(-106.9%) | $183.51 M(+37.3%) |
Dec 2022 | $152.47 M(-125.0%) | $207.72 M(+363.4%) | $133.65 M(-123.2%) |
Sep 2022 | - | $44.83 M(-182.0%) | -$576.48 M(-19.3%) |
Jun 2022 | - | -$54.64 M(-15.0%) | -$713.98 M(-3.8%) |
Mar 2022 | - | -$64.26 M(-87.2%) | -$742.54 M(+6.8%) |
Dec 2021 | -$609.50 M(-1150.6%) | -$502.42 M(+442.1%) | -$695.26 M(+110.0%) |
Sep 2021 | - | -$92.67 M(+11.4%) | -$331.07 M(+22.2%) |
Jun 2021 | - | -$83.19 M(+389.8%) | -$270.85 M(+22.1%) |
Mar 2021 | - | -$16.98 M(-87.7%) | -$221.86 M(-604.0%) |
Dec 2020 | $58.02 M(-152.2%) | -$138.22 M(+325.9%) | $44.02 M(-64.7%) |
Sep 2020 | - | -$32.46 M(-5.1%) | $124.80 M(-5.2%) |
Jun 2020 | - | -$34.20 M(-113.7%) | $131.65 M(-18.5%) |
Mar 2020 | - | $248.90 M(-533.3%) | $161.58 M(-246.0%) |
Dec 2019 | -$111.11 M(+68.1%) | -$57.44 M(+124.3%) | -$110.66 M(+5.0%) |
Sep 2019 | - | -$25.61 M(+499.8%) | -$105.36 M(+143.8%) |
Jun 2019 | - | -$4.27 M(-81.7%) | -$43.22 M(-35.6%) |
Mar 2019 | - | -$23.34 M(-55.2%) | -$67.08 M(+1.6%) |
Dec 2018 | -$66.09 M(-7.2%) | -$52.15 M(-242.8%) | -$66.01 M(+128.6%) |
Sep 2018 | - | $36.53 M(-229.8%) | -$28.88 M(-68.4%) |
Jun 2018 | - | -$28.13 M(+26.3%) | -$91.24 M(+15.7%) |
Mar 2018 | - | -$22.27 M(+48.4%) | -$78.86 M(+10.6%) |
Dec 2017 | -$71.20 M(+14.7%) | -$15.01 M(-41.9%) | -$71.33 M(-17.1%) |
Sep 2017 | - | -$25.84 M(+64.0%) | -$86.06 M(+17.4%) |
Jun 2017 | - | -$15.75 M(+6.9%) | -$73.33 M(+9.7%) |
Mar 2017 | - | -$14.73 M(-50.5%) | -$66.86 M(+8.6%) |
Dec 2016 | -$62.07 M(-332.1%) | -$29.74 M(+126.8%) | -$61.56 M(+25.3%) |
Sep 2016 | - | -$13.11 M(+41.2%) | -$49.14 M(+4.2%) |
Jun 2016 | - | -$9.28 M(-1.6%) | -$47.17 M(+6.4%) |
Mar 2016 | - | -$9.43 M(-45.5%) | -$44.34 M(-257.1%) |
Dec 2015 | $26.74 M | -$17.31 M(+55.3%) | $28.23 M(-36.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2015 | - | -$11.15 M(+72.7%) | $44.18 M(-15.8%) |
Jun 2015 | - | -$6.45 M(-110.2%) | $52.47 M(-11.8%) |
Mar 2015 | - | $63.14 M(-4735.2%) | $59.51 M(>+9900.0%) |
Dec 2014 | -$74.80 K(-100.4%) | -$1.36 M(-52.3%) | $152.10 K(-105.2%) |
Sep 2014 | - | -$2.86 M(-590.1%) | -$2.92 M(+37.3%) |
Jun 2014 | - | $582.60 K(-84.6%) | -$2.13 M(-111.3%) |
Mar 2014 | - | $3.79 M(-185.4%) | $18.82 M(-6.6%) |
Dec 2013 | $20.64 M(+71.3%) | -$4.43 M(+115.0%) | $20.14 M(-37.5%) |
Sep 2013 | - | -$2.06 M(-109.6%) | $32.21 M(-9.3%) |
Jun 2013 | - | $21.52 M(+321.2%) | $35.49 M(+123.8%) |
Mar 2013 | - | $5.11 M(-33.1%) | $15.86 M(+31.0%) |
Dec 2012 | $12.05 M(-51.6%) | $7.63 M(+522.2%) | $12.11 M(-428.1%) |
Sep 2012 | - | $1.23 M(-35.1%) | -$3.69 M(-47.7%) |
Jun 2012 | - | $1.89 M(+39.7%) | -$7.05 M(-52.1%) |
Mar 2012 | - | $1.35 M(-116.6%) | -$14.73 M(-160.9%) |
Dec 2011 | $24.89 M(-2.8%) | -$8.16 M(+282.8%) | $24.18 M(-37.8%) |
Sep 2011 | - | -$2.13 M(-63.2%) | $38.85 M(-13.2%) |
Jun 2011 | - | -$5.79 M(-114.4%) | $44.77 M(-22.4%) |
Mar 2011 | - | $40.26 M(+518.2%) | $57.68 M(+124.2%) |
Dec 2010 | $25.62 M(-0.1%) | $6.51 M(+72.0%) | $25.73 M(+4.6%) |
Sep 2010 | - | $3.79 M(-46.8%) | $24.59 M(-9.5%) |
Jun 2010 | - | $7.11 M(-14.4%) | $27.16 M(+6.9%) |
Mar 2010 | - | $8.31 M(+54.5%) | $25.41 M(-0.0%) |
Dec 2009 | $25.65 M(-24.8%) | $5.38 M(-15.4%) | $25.42 M(+26.8%) |
Sep 2009 | - | $6.36 M(+18.4%) | $20.04 M(+46.4%) |
Jun 2009 | - | $5.37 M(-35.5%) | $13.69 M(+64.5%) |
Mar 2009 | - | $8.32 M | $8.32 M |
Dec 2008 | $34.10 M(+81.6%) | - | - |
Dec 2007 | $18.78 M(-82.9%) | - | - |
Dec 2006 | $109.81 M(+126.7%) | - | - |
Dec 2005 | $48.45 M(+1088.2%) | - | - |
Dec 2004 | $4.08 M(-471.1%) | - | - |
Dec 2003 | -$1.10 M(-95.0%) | - | - |
Dec 2002 | -$22.12 M | - | - |
FAQ
- What is MorphoSys AG annual EBITDA?
- What is the all time high annual EBITDA for MorphoSys AG?
- What is MorphoSys AG annual EBITDA year-on-year change?
- What is MorphoSys AG quarterly EBITDA?
- What is the all time high quarterly EBITDA for MorphoSys AG?
- What is MorphoSys AG quarterly EBITDA year-on-year change?
- What is MorphoSys AG TTM EBITDA?
- What is the all time high TTM EBITDA for MorphoSys AG?
- What is MorphoSys AG TTM EBITDA year-on-year change?
What is MorphoSys AG annual EBITDA?
The current annual EBITDA of MOR is -$76.35 M
What is the all time high annual EBITDA for MorphoSys AG?
MorphoSys AG all-time high annual EBITDA is $152.47 M
What is MorphoSys AG annual EBITDA year-on-year change?
Over the past year, MOR annual EBITDA has changed by -$228.82 M (-150.08%)
What is MorphoSys AG quarterly EBITDA?
The current quarterly EBITDA of MOR is $59.38 M
What is the all time high quarterly EBITDA for MorphoSys AG?
MorphoSys AG all-time high quarterly EBITDA is $248.90 M
What is MorphoSys AG quarterly EBITDA year-on-year change?
Over the past year, MOR quarterly EBITDA has changed by -$148.34 M (-71.41%)
What is MorphoSys AG TTM EBITDA?
The current TTM EBITDA of MOR is -$56.19 M
What is the all time high TTM EBITDA for MorphoSys AG?
MorphoSys AG all-time high TTM EBITDA is $193.59 M
What is MorphoSys AG TTM EBITDA year-on-year change?
Over the past year, MOR TTM EBITDA has changed by -$189.84 M (-142.04%)